Faculty Spotlight: Marvin Medow
NYMC Study Identifies Effective Treatment for Individuals with POTS
NYMC Study Identifies Effective Treatment for Individuals with POTS
After studying patients suffering from a history of fainting and similar symptoms related to Postural Orthostatic Tachycardia Syndrome (POTS)—a circulation disorder characterized by insufficient flow of blood to the heart when moving from a lying down to standing position—investigators from New York Medical College (NYMC) saw their efforts published in The Journal for Pediatrics.
NYMC Celebrates 26th Annual Faculty Author Recognition
New York Medical College’s (NYMC) prolific faculty authors were recognized for their published works at the 26th Annual Faculty Author Celebration, hosted by the Health Sciences Library on September 25.
GSBMS Hosts Largest Summer Trainees in Academic Research (STAR) Program To Date
The Eighth Annual Summer Trainees in Academic Research (STAR) Program featured 35 poster presentations.
New Faculty Member Brings Groundbreaking Diabetes Research Program to NYMC
New York Medical College (NYMC) welcomes a rising star in diabetes research, Ercument Dirice, Ph.D., who joined the College community in April as assistant professor of pharmacology.
NYMC Researchers Aim to Transform Treatment of Babesiosis
New York Medical College (NYMC) researchers have made great strides in the fight against the tick-borne illnesses.
Robert B. Nadelman, M.D., Research Fellowship Pays Tribute to Esteemed Professor
In March of 2018, Robert B. Nadelman, M.D., long-standing professor of medicine at New York Medical College (NYMC) passed away and soon after, his students endeavored to find a way to honor the memory of their esteemed teacher.
BioInc@NYMC Is Expanding
With construction already underway, BioInc@NYMC announced its plans to add an additional 9,500 square feet to the biotechnology incubator in order to make room for up to 20 additional startup companies.
New York Medical College Team of Tick-Experts May Have Revolutionized Treatment of Babesiosis
Clinical trials on Tafenoquine as a treatment of Babesiosis are expected within the next two years
